Neurocrine Bio. (NBIX) PT Raised to $175 at Guggenheim
Tweet Send to a Friend
(Updated - July 31, 2025 9:52 AM EDT)
Guggenheim analyst Yatin Suneja raised the price target on Neurocrine Bio ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Guggenheim analyst Yatin Suneja raised the price target on Neurocrine Bio ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
